{
    "code": "10000919",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000919",
    "time": "2021-12-17 03:33:35",
    "許可證字號": "衛署菌疫輸字第000919號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/09\/08",
    "發證\/登錄日期": "100\/09\/08",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000091904",
    "中文品名": "倍血添注射劑",
    "英文品名": "Neulasta",
    "適應症": "適用於非骨髓性癌症患者在接受易引起臨床上有顯著發生率的嗜中性白血球減少症合併發燒之骨髓抑制性抗癌藥物治療時，以降低嗜中性白血球減少症合併發燒為表現之感染發生率。",
    "劑型": "270注射劑",
    "包裝": "0.6mL預充填注射針筒 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Pegfilgrastim",
    "限制項目": "02輸　入",
    "申請商名稱": "1902001100  台灣協和麒麟股份有限公司",
    "申請商地址": "台北市中山區中山北路二段68號9樓",
    "主製造廠": [
        {
            "": "PUERTO RICO",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200093700",
            "成分名稱": "Pegfilgrastim",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[藥物外觀圖檔] Neulasta_2020Mar-109-11-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=367&Type=10"
        },
        {
            "title": "[藥物外觀圖檔] Neulasta_2020Mar-109-03-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=366&Type=10"
        },
        {
            "title": "[藥物外觀圖檔] Neulasta_2018SEP-107-09-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=365&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件2 [Clean] Neulasta_中文PI_202012-110-09-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=011&Type=9"
        },
        {
            "title": "[外盒圖檔] Neulasta_2020Oct-109-11-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=007&Type=8"
        },
        {
            "title": "[外盒圖檔] Neulasta_2020Mar-109-03-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=006&Type=8"
        },
        {
            "title": "[外盒圖檔] Neulasta_2018SEP-107-09-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000919&Seq=005&Type=8"
        }
    ]
}